Metabolomic Technologies Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Metabolomic Technologies Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011039
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metabolomic Technologies Inc (MTI) is a biotechnology company that develops metabolomic-based diagnostic systems. The company’s products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastrointestinal diseases in their early stages. MTI’s products are used in the treatment of breast cancer, prostate cancer, celiac disease, ulcerative colitis, Crohn’s disease, IBD, lactose intolerance, acid reflux and gastric ulcers. The company partners with various researchers to commercialize and distribute its products. It provides metabolomics analysis for various applications including sample preparation, data collection, statistical analysis, and interpretation. It also conducts research and development program to identify metabolomic fingerprints in urine samples. MTI is headquartered in Edmonton, Alberta, Canada.

Metabolomic Technologies Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metabolomic Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Metabolomic Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Metabolomic Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Metabolomic Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Metabolomic Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Metabolomic Technologies Inc, Medical Equipment, Deal Details 10
Partnerships 10
Lab Express Enters into Licensing Agreement with Metabolomic Technologies 10
Atlantic Diagnostic Labs Enters into Licensing Agreement with Metabolomic Technologies 11
Metabolomic Technologies Enters Into Co-Development Agreement With BGI Shenzhen For PolypDx 12
Metabolomic Technologies Inc – Key Competitors 13
Metabolomic Technologies Inc – Key Employees 14
Metabolomic Technologies Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Metabolomic Technologies Inc, Medical Equipment, Key Facts 2
Metabolomic Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Metabolomic Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Metabolomic Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Metabolomic Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Metabolomic Technologies Inc, Deals By Market, 2011 to YTD 2017 8
Metabolomic Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Lab Express Enters into Licensing Agreement with Metabolomic Technologies 10
Atlantic Diagnostic Labs Enters into Licensing Agreement with Metabolomic Technologies 11
Metabolomic Technologies Enters Into Co-Development Agreement With BGI Shenzhen For PolypDx 12
Metabolomic Technologies Inc, Key Competitors 13
Metabolomic Technologies Inc, Key Employees 14

★海外企業調査レポート[Metabolomic Technologies Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UDG Healthcare Plc (UDG):企業の財務・戦略的SWOT分析
    UDG Healthcare Plc (UDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Alamos Gold Inc:企業の戦略・SWOT・財務分析
    Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PSE Kinsale Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary PSE Kinsale Energy Ltd (Kinsale Energy), formerly Marathon Oil Ireland Limited, carries out the production and storage of natural gas from its facilities off the Old Head of Kinsale. The company operates Kinsale Head, Ballycotton, Seven Heads and Southwest Kinsale gas fields in the Celtic Se …
  • Microgen plc (MCGN):企業の財務・戦略的SWOT分析
    Microgen plc (MCGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Denka Co Ltd (4061):企業の財務・戦略的SWOT分析
    Denka Co Ltd (4061) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Biotest AG (BIO):企業の財務・戦略的SWOT分析
    Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Strat Aero Plc (AERO):企業の財務・戦略的SWOT分析
    Summary Strat Aero Plc (Strat Aero) formally known as Remote Monitored Systems PLC is an aerospace company that offers management systems, training solutions and consultancy services to the Unmanned Aerial Vehicle (UAV) sector. The company’s services include survey and inspection services, surveilla …
  • Cranswick Plc
    Cranswick Plc - Strategy, SWOT and Corporate Finance Report Summary Cranswick Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Quidel Corp (QDEL):医療機器:M&Aディール及び事業提携情報
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析
    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Credit Suisse (UK) Private Banking:企業の戦略・SWOT・財務分析
    Credit Suisse (UK) Private Banking - Strategy, SWOT and Corporate Finance Report Summary Credit Suisse (UK) Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Numedii Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Numedii Inc (Numedii) is a life science technology company that discovers and develops new drug candidates by translating life sciences big data into therapies. The company uses life sciences big data technology to discover and de-risk molecular entities based on therapeutically relevant bio …
  • Damodar Valley Corp:企業の戦略的SWOT分析
    Damodar Valley Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • BlueCrest Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary BlueCrest Energy Inc (BlueCrest) is a privately held exploration and production company. The company primary focused on the extraction, acquisition, drilling, developing, and exploration of oil and gas resources within Alaska, the US. BlueCrest’ soil and gas assets are located approximately …
  • Nuvo Pharmaceuticals Inc (NRI):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical instruments for functional cellular analyses. The company’s liquid biopsy technologies include IsoFlux CTC liquid biopsy system, ERASE-Seq variant caller for liquid biopsies and the Spotlight 59 for ultra-sensitive NGS mutation de …
  • Companhia Energetica de Minas Gerais SA (CMIG4):電力:M&Aディール及び事業提携情報
    Summary Companhia Energetica de Minas Gerais SA (CEMIG) is an integrated energy utility. Through its subsidiaries and jointly-controlled investees, the company has presence in the electricity vertical. The company produces power from biomass, wind, solar, hydro, fossil, and nuclear sources; and proc …
  • Aeglea BioTherapeutics Inc (AGLE)-製薬・医療分野:企業M&A・提携分析
    Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB …
  • Helios and Matheson Analytics Inc (HMNY):企業の財務・戦略的SWOT分析
    Summary Helios and Matheson Analytics Inc (Helios and Matheson) is a big data company. It offers IT infrastructure, social data aggregation, cognitive computing, map-tech innovation, application development, pattern discovery solutions. The company's analytic solutions find application across a broa …
  • Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報
    Summary Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens nat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆